Allergan Reveals Deals on Q3 Call, But Not With Pfizer
This article was originally published in Scrip
Executive Summary
Allergan PLC kept mum on its ongoing merger discussions with Pfizer Inc. during its third quarter earnings call Nov. 4, citing Irish takeover laws, but the company still revealed deal news and indicated it is aggressively evaluating business development opportunities.